AS1 and Don Whitley to exhibit at CHRO Conference

AS1 will be jointly exhibiting with Don Whitley Scientific at the 18th international workshop on Campylobacter, Helicobacter and related organisms - CHRO 2015 and 2015 NZMS Conference.

CHRO 2015 will be held in the beautiful spa town of Rotorua in New Zealand from 1-5 November 2015. Rotorua offers a stunning natural environment for the conference and activities for all to enjoy, as well as state-of-the-art conference facilities and accommodation to suit every budget.

We will be showcasing a Don Whitley A35 anaerobic cabinet and releasing the new M35 microaerophilic cabinet.

We will have Biolog consumables and other products in our range showcased as well.

Would you like more information about the event or where we will be located? Please contact Anna.

AS1 Attends NZMS/NZSBMB Conference

AS1 attended the annual conference of the New Zealand Microbiological Society Inc and the New Zealand Society for Biochemistry and Molecular Biology in November.

The focus of this years conference was the challenge of being a scientist in the post-genomic era. The conference presentations discussed the challenge of functional genomics, New Zealand’s biological heritage and science for technological innovation.

AS1 display visitors were particularly interested in Biolog, DWS Anaerobic and Hypoxia cabinets, and Presens oxygen monitoring systems

It was an excellent meeting with a lot of interesting presentations and posters.

For more information about the event or a product, please Contact Anna.

Dr. Barry Bochner to visit New Zealand

AS1 is pleased to announce, Dr. Barry Bochner will be presenting in New Zealand. Read his Biography and Presenting Schedule and contact Anna if you are interested in attending.

TITLE:  Phenotype MicroArrays: An Overview of the Technology and Applications

PRESENTER:  Barry R. Bochner, Ph.D., CEO & CSO, Biolog, Inc., Hayward, CA  Biography and New Zealand Presenting Schedule

Phenotype MicroArray (PM) technology allows a biologist to test thousands of phenotypes of a cell line in a single experiment, to gain a comprehensive overview of the metabolism, physiology, and pathway fluxes.It provides phenomic and metabolomic information that is complementary to genomic or proteomic analysis and often more easy to interpret and more useful.The PM technology platform is applicable to a wide range of cells including bacterial, fungal, or animal and enables metabolic analysis in the context of genotype-phenotype studies.  For example, it can be used for (1) analyzing cells with mutations to determine the metabolic and physiologic effects of genetic differences, (2) studying and defining cell metabolism and metabolic regulation, (3) understanding the interplay of environment and hormonal signals on cell metabolism and physiology, (4) optimizing cell culture conditions, and (5) looking at the effects of drugs and other chemicals on cellular pathways.  For microbial cells, recent work has demonstrated the utility of the technology for determining culture conditions that turn on and turn off production of toxins and other secondary metabolites that microbes can produce.  The technology also has many applications with human cells, including the assay of the effects of microbial toxins.  Specific examples and discoveries will be presented to illustrate the many uses of PM technology.